Medical Devices Investors & VC Firms in United States
886 firms in this list, with a median first check of $500K. 188 of them lead rounds. Generated from verified public data and updated continuously.
NYBC Ventures
New YorkSeed–Series B
8 people
Linden Capital
ChicagoPre-Seed–Series A
2 people
Altium Capital
New YorkSeed–Growth
7 people
Jumpstart Capital
NashvilleSeed–Series A$250K – $500K
4 people
InnoCom Bio Equities
San FranciscoPre-Seed–Series A
9 people
Newpath Partners
BostonSeed–Series A$50K – $10M
3 people
Zoic Capital
SeattleSeed–Series A
12 people
Incubic Management LLC
Los Altos HillsPre-Seed–Series A$100K – $5M
2 people
20/20 HealthCare Partners LLC
AuburndaleSeed–Late Stage
7 people
University of Cambridge Enterprise
CambridgePre-Seed–Late Stage
10 people
VTC Ventures
RoanokePre-Seed–Series B$100K – $5M
4 people
Anthropy Partners
SeattlePre-Seed–Series A
6 people
Invest Michigan
NorthvillePre-Seed–Series A$100K – $250K
3 people
Scientific Health Development
DallasPre-Seed–Series A$2M
6 people
Arlington Capital Partners
BethesdaSeries A
5 people
Narya Capital
ColumbusPre-Seed–Late Stage
5 people
BioGenerator Ventures
St. LouisPre-Seed–Series B$50K – $250K
1 person
SyndicateRoom
CambridgePre-Seed–Series A
4 people
Lucas Venture Group
Palo AltoPre-Seed–Series A$1M – $5M
6 people
BioCrossroads
IndianapolisSeed
11 people
Brown and White Ventures
FairportPre-Seed–Seed
7 people
Diamond Edge Ventures
San FranciscoSeed–Series A
7 people
KIC Ventures
Fort LauderdaleSeed–Late Stage
10 people
Pandect Bioventures
WoodsideSeed–Late Stage
10 people
Related lists
Investors & VC Firms in North America (14139)Investors & VC Firms in United States (13277)Investors & VC Firms in Europe (5574)Crypto & Web3 Investors & VC Firms (4829)Investors & VC Firms in Global (4159)SaaS Investors & VC Firms (3860)AI & Machine Learning Investors & VC Firms (3768)Fintech Investors & VC Firms (3725)Investors & VC Firms in Asia-Pacific (3573)Healthtech Investors & VC Firms (3414)
Data sourced from public filings and firms' own websites — see our methodology.








































































